Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)R Gervais, A Ducolone, J-L Breton, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomised phase II study. The EORTC Lung Cancer Cooperative groupP E Postmus, T A Splinter, F M Palmen, et al.The European Respiratory Journal|June 11, 2011
Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3I Borget, J Cadranel, J-P Pignon, et al.Revue Des Maladies Respiratoires|June 24, 2010
[Management and outcome of French elderly patients with lung cancer: an IFCT survey]E Quoix, I Monnet, P Scheid, et al.European Journal of Cancer (Oxford, England : 1990)|November 7, 2003
Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progressionM Beau-Faller, M P Gaub, A Schneider, et al.British Journal of Cancer|March 19, 2009
Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clampingM Beau-Faller, M Legrain, A-C Voegeli, et al.British Journal of Cancer|May 20, 2004
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patientsJ-L Pujol, O Molinier, W Ebert, et al.Journal of the National Cancer Institute|February 22, 2001
Etoposide plus cisplatin with or without the combination of 4'-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized studyJ L Pujol, J P Daurès, A Rivière, et al.British Journal of Cancer|December 17, 2008
Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancerM J McKeage, J Von Pawel, M Reck, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III studyJ L Pujol, J Y Douillard, A Rivière, et al.Pageof 14